SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-213271
Filing Date
2020-08-07
Accepted
2020-08-07 17:57:51
Documents
17
Period of Report
2020-08-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d49183d8k.htm   iXBRL 8-K 29881
2 EX-1.1 d49183dex11.htm EX-1.1 201822
3 EX-5.1 d49183dex51.htm EX-5.1 23251
7 GRAPHIC g49183dsp001.jpg GRAPHIC 9491
8 GRAPHIC g49183dsp002.jpg GRAPHIC 25439
9 GRAPHIC g49183dsp003.jpg GRAPHIC 2364
  Complete submission text file 0001193125-20-213271.txt   490972

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hznp-20200806.xsd EX-101.SCH 3083
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20200806_lab.xml EX-101.LAB 18838
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20200806_pre.xml EX-101.PRE 11847
10 EXTRACTED XBRL INSTANCE DOCUMENT d49183d8k_htm.xml XML 3603
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 201085715
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences